7h
Zacks Investment Research on MSNPfizer (PFE) Stock Moves -0.43%: What You Should KnowThe most recent trading session ended with Pfizer (PFE) standing at $25.60, reflecting a -0.43% shift from the previouse trading day's closing. This change was narrower than the S&P 500's daily loss ...
AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.
Summit Therapeutics (NASDAQ: SMMT) has been one of the hottest stocks to own over the past 12 months, with its valuation ...
Morgan Stanley lowered the firm’s price target on Arvinas (ARVN) to $12 from $48 and keeps an Equal Weight rating on the shares after the ...
This article has been corrected to reflect that the senators asked UpScriptHealth to respond. In August 2024, Pfizer Inc ...
Taylen Green returns to quarterback the Razorbacks in 2025, but few targets that he threw to in 2024 will be back.
The Hopkins School Board heard from the district's special education department at its latest work session, learning its day-to-day functions and how it has been chronically plagued by budget dilemmas ...
Passat brake pedal felt soft and went to the floor in July 2024. My shop determined air was in the lines and bled the brakes. The problem ...
Columnist Ann Coulter says Biden’s mass clemencies overturned federal law, freeing 4,000 criminals and commuting death ...
Our High Voltage column wraps all the news driving ASX stocks with exposure to lithium, cobalt, graphite, nickel, rare earths ...
PACCAR utilizes its comprehensive Supplier Performance Management Program (SPM) to evaluate supplier achievements in the areas of product development, operations, aftermarket support, and alignment ...
Pfizer is ranked third among the best pharma stocks to buy according to hedge funds. The company boasts a strong oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results